| Product Code: ETC6186031 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Australia`s market for neonatal jaundice management has seen significant improvements through the adoption of early screening and effective phototherapy techniques. Hospitals utilize both conventional and LED-based phototherapy units, alongside diagnostic bilirubinometers. Public health efforts to educate about jaundice in newborns have led to earlier detection and treatment, improving neonatal outcomes.
In Australia, the neonatal jaundice management market is witnessing increased use of early screening and home-based phototherapy units. The adoption of non-invasive bilirubin meters and standardized treatment protocols across healthcare institutions is enhancing diagnosis and treatment efficiency. Additionally, public and private sector collaboration in promoting neonatal screening is positively influencing the market.
The market for neonatal jaundice management in Australia faces challenges due to the increasing number of cases of jaundice among newborns. The primary challenge is ensuring timely diagnosis and intervention, as untreated jaundice can lead to severe complications, including brain damage. There is also the challenge of developing more effective and affordable treatments for jaundice, such as phototherapy devices, and ensuring their availability in all healthcare settings. Additionally, there is a growing need for non-invasive jaundice monitoring technologies to improve patient comfort and outcomes.
With jaundice affecting a large proportion of newborns, phototherapy remains a staple in neonatal care. However, there`s a rising demand for wearable phototherapy devices, portable LED-based treatment systems, and digital bilirubin monitoring tools. Investors can explore manufacturing and distribution of compact and home-usable phototherapy solutions, especially in collaboration with maternal care units and pediatric clinics.
The neonatal jaundice management market in Australia is regulated by TGA guidelines that ensure the safety and efficacy of devices and treatments for managing jaundice in newborns. Policies aimed at reducing the incidence of severe neonatal jaundice and promoting early diagnosis influence market demand. Government funding for research into phototherapy treatments and innovations in non-invasive jaundice management technologies also drive market growth. These policies emphasize improving neonatal care outcomes by providing timely and effective interventions for jaundice.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Neonatal Jaundice Management Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Neonatal Jaundice Management Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Neonatal Jaundice Management Market - Industry Life Cycle |
3.4 Australia Neonatal Jaundice Management Market - Porter's Five Forces |
3.5 Australia Neonatal Jaundice Management Market Revenues & Volume Share, By Management, 2021 & 2031F |
3.6 Australia Neonatal Jaundice Management Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Australia Neonatal Jaundice Management Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Australia Neonatal Jaundice Management Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Australia Neonatal Jaundice Management Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Neonatal Jaundice Management Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neonatal jaundice in Australia |
4.2.2 Technological advancements in neonatal jaundice management |
4.2.3 Growing investments in healthcare infrastructure and neonatal care facilities |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for neonatal jaundice management products |
4.3.2 Limited awareness about neonatal jaundice management among healthcare professionals and parents |
5 Australia Neonatal Jaundice Management Market Trends |
6 Australia Neonatal Jaundice Management Market, By Types |
6.1 Australia Neonatal Jaundice Management Market, By Management |
6.1.1 Overview and Analysis |
6.1.2 Australia Neonatal Jaundice Management Market Revenues & Volume, By Management, 2021- 2031F |
6.1.3 Australia Neonatal Jaundice Management Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.4 Australia Neonatal Jaundice Management Market Revenues & Volume, By Treatment, 2021- 2031F |
6.2 Australia Neonatal Jaundice Management Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Australia Neonatal Jaundice Management Market Revenues & Volume, By Primary Care, 2021- 2031F |
6.2.3 Australia Neonatal Jaundice Management Market Revenues & Volume, By Secondary Care, 2021- 2031F |
6.3 Australia Neonatal Jaundice Management Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Australia Neonatal Jaundice Management Market Revenues & Volume, By Light-Emitting Diode Light Sources, 2021- 2031F |
6.3.3 Australia Neonatal Jaundice Management Market Revenues & Volume, By Fluorescent, 2021- 2031F |
6.3.4 Australia Neonatal Jaundice Management Market Revenues & Volume, By Halogen, 2021- 2031F |
6.3.5 Australia Neonatal Jaundice Management Market Revenues & Volume, By Fiberoptic, 2021- 2031F |
6.3.6 Australia Neonatal Jaundice Management Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Neonatal Jaundice Management Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Australia Neonatal Jaundice Management Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Australia Neonatal Jaundice Management Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Australia Neonatal Jaundice Management Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.4.5 Australia Neonatal Jaundice Management Market Revenues & Volume, By Home Users, 2021- 2031F |
6.4.6 Australia Neonatal Jaundice Management Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Australia Neonatal Jaundice Management Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Australia Neonatal Jaundice Management Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.5.3 Australia Neonatal Jaundice Management Market Revenues & Volume, By Retail Sales, 2021- 2031F |
6.5.4 Australia Neonatal Jaundice Management Market Revenues & Volume, By Third Party Distribution, 2021- 2031F |
7 Australia Neonatal Jaundice Management Market Import-Export Trade Statistics |
7.1 Australia Neonatal Jaundice Management Market Export to Major Countries |
7.2 Australia Neonatal Jaundice Management Market Imports from Major Countries |
8 Australia Neonatal Jaundice Management Market Key Performance Indicators |
8.1 Number of neonatal jaundice cases diagnosed and treated annually |
8.2 Adoption rate of advanced neonatal jaundice management technologies |
8.3 Rate of investment in research and development for new neonatal jaundice management solutions |
9 Australia Neonatal Jaundice Management Market - Opportunity Assessment |
9.1 Australia Neonatal Jaundice Management Market Opportunity Assessment, By Management, 2021 & 2031F |
9.2 Australia Neonatal Jaundice Management Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Australia Neonatal Jaundice Management Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Australia Neonatal Jaundice Management Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Australia Neonatal Jaundice Management Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Neonatal Jaundice Management Market - Competitive Landscape |
10.1 Australia Neonatal Jaundice Management Market Revenue Share, By Companies, 2024 |
10.2 Australia Neonatal Jaundice Management Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here